Free fatty acids increase PGC-1α expression in isolated rat islets

被引:42
作者
Zhang, PX
Liu, C
Zhang, CN
Zhang, Y
Shen, PP
Zhang, JF
Zhang, CY
机构
[1] Nanjing Univ, Sch Life Sci, Inst Mol Med, Nanjing 210093, Peoples R China
[2] Nanjing Univ, Sch Life Sci, State Key Lab Pharmaceut Biotechnol, Nanjing 210093, Peoples R China
基金
中国国家自然科学基金;
关键词
PGC-1; alpha; free fatty acids; beta-cell dysfunction;
D O I
10.1016/j.febslet.2005.01.046
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
PGC-1alpha mRNA and protein are elevated in islets from multiple animal models of diabetes. Overexpression of PGC-lalpha impairs glucose-stimulated insulin secretion (GSIS). However, it is not well known which metabolic events lead to upregulation of PGC-la in the P-cells under pathophysiological condition. In present study, we have investigated effects of chronic hyperlipidemia and hyperglycemia on PGC-la mRNA expression in isolated rat islets. Isolated rat islets are chronically incubated with 0, 0.2,and 0.4 mM oleic acid/palmitic acid (free fatty acids, FFA) or 5.5 and 25 mM glucose for 72 h. FFA dose-dependently increases PGC-lot mRNA expression level in isolated islets. FFA also increases PGC-1alpha expression in mouse eta-cell-derived betaTC3 cell line. In contrast, 25 mM glucose decreases expression level of PGC-la. Inhibition of PGC-lalpha by siRNA improves FFA-induced impairment of GSIS in islets. These data suggest that hyperlipidemia and hyperglycernia regulate PGC-lalpha expression in islets differently, and elevated PGC-la by FFA plays an important role in chronic hyperlipidemia-induced beta-cell dysfunction. (C) 2005 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:1446 / 1452
页数:7
相关论文
共 44 条
  • [1] ABNORMAL REGULATION OF CAMP ACCUMULATION IN PANCREATIC-ISLETS OF OBESE MICE
    BLACK, MA
    HEICK, HMC
    BEGINHEICK, N
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY, 1988, 255 (06): : E833 - E838
  • [2] Chan CB, 1996, INT J OBESITY, V20, P175
  • [3] Increased uncoupling protein-2 levels in β-cells are associated with impaired glucose-stimulated insulin secretion -: Mechanism of action
    Chan, CB
    De Leo, D
    Joseph, JW
    McQuaid, TS
    Ha, XF
    Xu, F
    Tsushima, RG
    Pennefathner, PS
    Salapatek, AMF
    Wheeler, MB
    [J]. DIABETES, 2001, 50 (06) : 1302 - 1310
  • [4] Overexpression of uncoupling protein 2 inhibits glucose-stimulated insulin secretion from rat islets
    Chan, CB
    MacDonald, PE
    Saleh, MC
    Johns, DC
    Marbàn, E
    Wheeler, MB
    [J]. DIABETES, 1999, 48 (07) : 1482 - 1486
  • [5] Inverse relationship between cytotoxicity of free fatty acids in pancreatic islet cells and cellular triglyceride accumulation
    Cnop, M
    Hannaert, JC
    Hoorens, A
    Eizirik, DL
    Pipeleers, DG
    [J]. DIABETES, 2001, 50 (08) : 1771 - 1777
  • [6] DANDENOUWELAND JM, 1992, NAT GENET, V1, P368
  • [7] Peroxisome proliferator-activated receptor γ coactivator-1-dependent uncoupling protein-2 expression in pancreatic islets of rats:: a novel pathway for neural control of insulin secretion
    De Souza, CT
    Gasparetti, AL
    Pereira-da-Silva, M
    Araújo, EP
    Carvalheira, JB
    Saad, MJA
    Boschero, AC
    Carneiro, EM
    Velloso, LA
    [J]. DIABETOLOGIA, 2003, 46 (11) : 1522 - 1531
  • [8] Type VIII adenylyl cyclase in rat beta cells: coincidence signal detector/generator for glucose and GLP-1
    Delmeire, D
    Flamez, D
    Hinke, SA
    Cali, JJ
    Pipeleers, D
    Schuit, F
    [J]. DIABETOLOGIA, 2003, 46 (10) : 1383 - 1393
  • [9] Human peroxisome proliferator activated receptor gamma coactivator 1 (PPARGC1) gene:: cDNA sequence, genomic organization, chromosomal localization, and tissue expression
    Esterbauer, H
    Oberkofler, H
    Krempler, F
    Patsch, W
    [J]. GENOMICS, 1999, 62 (01) : 98 - 102
  • [10] β-cell mass dynamics in Zucker diabetic fatty rats -: Rosiglitazone prevents the rise in net cell death
    Finegood, DT
    McArthur, MD
    Kojwang, D
    Thomas, MJ
    Topp, BG
    Leonard, T
    Buckingham, RE
    [J]. DIABETES, 2001, 50 (05) : 1021 - 1029